Omnicell (OMCL) Cash from Investing Activities Growth (3y) (2013 - 2026)
Powered by 
Analysis
Omnicell (OMCL) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 17.83% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.99% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -44.28% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -6.23% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -32.54% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -68.12% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 18.69% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 37.39% |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -102.03% |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 5.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.43% |
| Mar 31, 2026 | -5.17% |
| Dec 31, 2025 | 5.80% |
| Sep 30, 2025 | 3.45% |
| Jun 30, 2025 | -32.68% |
| Mar 31, 2025 | 5.64% |
| Dec 31, 2024 | 58.68% |
| Sep 30, 2024 | 59.01% |
| Jun 30, 2024 | -0.49% |
| Mar 31, 2024 | 2.05% |
| Dec 31, 2023 | 62.61% |
| Sep 30, 2023 | -12.51% |
| Jun 30, 2023 | 8.65% |
| Mar 31, 2023 | 0.33% |
| Dec 31, 2022 | -5.00% |
| Sep 30, 2022 | -2.32% |
| Jun 30, 2022 | 23.54% |
| Mar 31, 2022 | -3.91% |
| Dec 31, 2021 | -146.13% |
| Sep 30, 2021 | -143.59% |